Concepedia

Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes

Yen‐Min Huang, Wan‐Ming Chen, An-Tzu Jao, Mingchih Chen, Ben‐Chang Shia, Szu‐Yuan Wu

Diabetes & Metabolism · 2023 · 31 citations · 31 references

DOI

Concepts

References

31

Cancer Statistics, 2021

Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2021 · 17.4K citations · Full text

, , +16

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca et al. · New England Journal of Medicine · 2018 · 6.3K citations · Full text

, , +17

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Vlado Perkovic, Meg Jardine, Bruce Neal et al. · New England Journal of Medicine · 2019 · 6K citations · Full text

, , +17

Dapagliflozin in Patients with Chronic Kidney Disease

Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter et al. · New England Journal of Medicine · 2020 · 5.2K citations · Full text

, , +16

Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studies

Peter C. Austin · Pharmaceutical Statistics · 2010 · 3.9K citations · Full text

, , +12